BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi HY, Wang K, Wang RH, Wu YE, Tang BH, Li X, Du B, Kan M, Zheng Y, Xu BP, Shen AD, Su LQ, Jacqz-Aigrain E, Huang X, Zhao W. Developmental population pharmacokinetics-pharmacodynamics and dosing optimization of cefoperazone in children. J Antimicrob Chemother 2020;75:1917-24. [PMID: 32129861 DOI: 10.1093/jac/dkaa071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Zhang J, Chen Y, Wu J, Guo B, Wu X, Zhang Y, Wang M, Ya R, Huang H. Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia. Antibiotics (Basel) 2022;11:703. [PMID: 35625347 DOI: 10.3390/antibiotics11050703] [Reference Citation Analysis]
2 Schouwenburg S, Wildschut ED, de Hoog M, Koch BCP, Abdulla A. The Pharmacokinetics of Beta-Lactam Antibiotics Using Scavenged Samples in Pediatric Intensive Care Patients: The EXPAT Kids Study Protocol. Front Pharmacol 2021;12:750080. [PMID: 34955824 DOI: 10.3389/fphar.2021.750080] [Reference Citation Analysis]
3 Du B, Zhou Y, Tang BH, Wu YE, Yang XM, Shi HY, Yao BF, Hao GX, You DP, van den Anker J, Zheng Y, Zhao W. Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance. Front Pharmacol 2021;12:630047. [PMID: 33790793 DOI: 10.3389/fphar.2021.630047] [Reference Citation Analysis]